Targeting central nervous system pathologies with nanomedicines
Authors:
- 18 October 2018
- journal article
- review article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 27 (5-6) , 542-554
Abstract
One of the major challenges in drug development is the delivery of therapeutics to the central nervous system (CNS). The blood-brain barrier (BBB), which modulates the passage of molecules from the CNS, presents a formidable obstacle that limits brain uptake of therapeutics and, therefore, impedes the treatment of multiple neurological pathologies. Targeted nanocarriers present an excellent opportunity for drug delivery into the brain leveraging on endogenous receptors to transport therapeutics across the BBB endothelium. Receptor-mediated transport endows multiple benefits over other conventional delivery methods such as the transient permeabilization of the BBB or the direct depositioning of intracranial depots. Herein, different strategies for nanocarrier targeting to the CNS are discussed, highlighting the challenges and recent developments.Keywords
Funding Information
- Israel Cancer Research Fund
- Israel Science Foundation (754490])
This publication has 147 references indexed in Scilit:
- Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Cancers, 2013
- Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s DiseasePLOS ONE, 2013
- Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cellsFluids and Barriers of the CNS, 2013
- Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier ModelPLOS ONE, 2012
- Morphine metabolism, transport and brain dispositionMetabolic Brain Disease, 2011
- Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in GlioblastomaPharmaceuticals, 2011
- Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumorsDrug Delivery and Translational Research, 2010
- CNS Delivery Via Adsorptive TranscytosisThe AAPS Journal, 2008
- Blood–Brain Barrier Transport of Therapeutics via Receptor-MediationPharmaceutical Research, 2007
- Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood–brain barrier disruptionProceedings of the National Academy of Sciences, 2006